A CONTROLLED RELEASE POROPLASTIC WOUND DRESSING WITH BACITRACIN AND POLYMIXIN B

Award Information
Agency:
Department of Defense
Branch:
Army
Amount:
$61,308.00
Award Year:
1987
Program:
SBIR
Phase:
Phase I
Contract:
N/A
Agency Tracking Number:
6153
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Moleculon Research Corp
230 Albany St, Cambridge, MA, 02139
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 DR S JAMES DAVIDSON
 (617) 577-9900
Business Contact
Phone: () -
Research Institution
N/A
Abstract
A CONTROLLED RELEASE ANTIBIOTIC WOUND DRESSING IS TO BE DEVELOPED FOR ADMINISTRATION OF BACITRACIN AND POLYMIX B. THE DRESSING IS TO BE EASILY APPLIED AND CONFORMABLE TO WOUND SURFACES. BOTH ANTIBIOTICS ARE TO BE MAINTAINED AT EFFECTIVE LEVELS WITHIN WOULDS FOR THREE DAYS, PREVENTING INFECTION FOR THIS PERIOD OF TIME. THE DRESSING IS TO BE INCORPORATED INTO POROPLASTIC CELLULOSE TRIACETATE MEMBRANES IN A FORMULATION DEVELOPED TO PROVIDE THE REQUIRED FUNCTIONAL PROPERTIES. THE EXPERIMENTAL APPROACH TO BE FOLLOWED IN DEVELOPMENT WILL BE BASED UPON EXPERIENCE GAINED IN DEVELOPING THE POROPLASTIC MEMBRANE CONTROLLED RELEASE DRESSING FOR DELIVERY OF GENTAMICIN AND CLINDAMYCIN PHOSPHATE. DURING PHASE I, REQUIRED ANALYTICAL METHODS WILL BE VALIDATED. THE SOLUBILITY BEHAVIOR OF THE ANTIBIOTICS WILL BE INVESTIGATED TO ESTABLISH THE BASIS FOR DRESSING FORMULATION. INITIAL DRESSING FORMULATIONS WILL BE PREPARED, AND THEIR ANTIBIOTIC DELIVERY PROPERTIES WILL BE STUDIED IN DIFFUSION CELLS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government